P

PathoCapital

North America, Illinois, United States, Northbrook

Description

PathoCapital is a venture fund that finances companies in the healthcare industry.

Investor Profile

PathoCapital has made 6 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Series C (17%)
  • Series Unknown (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Digital Signage
  • Information Technology
  • Medical Device
  • Wearables
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PathoCapital frequently co-invest with?

SC
North America, California, United States, San Francisco
Co-Investments: 2
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 4
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Beecken Petty O'Keefe & Company
North America, Illinois, United States, Chicago
Co-Investments: 2
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 5
GP
North America, Illinois, United States, Chicago
Co-Investments: 3
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2
DB
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 3
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 5

What are some of recent deals done by PathoCapital?

Aptinyx

Evanston, Illinois, United States

Aptinyx Inc. is a biopharmaceutical company.

BiopharmaBiotechnologyHealth CareMedical
Series BDec 18, 2017
Amount Raised: $70,000,000
Aptinyx

Evanston, Illinois, United States

Aptinyx Inc. is a biopharmaceutical company.

BiopharmaBiotechnologyHealth CareMedical
Series AMay 10, 2016
Amount Raised: $65,000,000
ReliefBand Technologies

Horsham, Pennsylvania, United States

ReliefBand Technologies designs and develops digital wearable devices that provide therapies for nausea and morning sickness.

Digital SignageHealth CareInformation TechnologyMedicalMedical DeviceWearables
Series UnknownDec 15, 2015
Amount Raised: $5,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series CDec 3, 2014
Amount Raised: $80,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series BDec 17, 2012
Amount Raised: $38,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series AMay 11, 2011
Amount Raised: $18,000,000